London-based LabGenius raises over €40.1 million to further develop its ML-driven antibody discovery platform

Published on May 21, 2024

London-based LabGenius, a drug discovery company pioneering the use of machine learning for the discovery of novel therapeutic antibodies, today announced that it has closed a Series B financing round of over €40.1 million. The investment brings LabGenius’ total funding to date to more than €67.8 million. The round was led by new investor M…

This content is for members only. Visit the site and log in/register to read.

The post London-based LabGenius raises over €40.1 million to further develop its ML-driven antibody discovery platform appeared first on EU-Startups.

Continue reading on website
Other news

Danish industrial biotech startup Cellugy raises €4.9 million to replace petrochemicals in personal care products

May 21, 2024
Søborg-based Cellugy, a Danish industrial biotech startup developing innovative, natural, biofabricated cellulose-based solutions to replace fossil-based materials in various industrial applications, has raised €4.9 million in seed funding to scale up production of its EcoFLEXY dry cellulose product to industrial volumes. The round was led by Germany’s ICIG Ventures and Denmark’s Unconventional Ve

Swiss-based Limula raised over €6.2 million aiming to democratise access to life-saving cell and gene therapies

May 21, 2024
Over the last decade, several breakthrough Cell and Gene Therapy products have been approved in the USA and Europe to turn stem cells and immune cells into ‘living cures’, bringing hope to millions living with life-threatening conditions. However, these treatments remain out of reach for 98% of patients suffering from what are now curable conditions…. This content is for members only. Visit the si